Post-Market 2.0: how continuous Real-World Evidence is redefining medical devices
There’s a silent but radical shift reshaping the value of medical devices, more than any new technology or algorithm. A shift born in real life: in patients’ routines, phones, homes, and clinical journeys. Its name is Real-World Evidence (RWE).And it is turning post-market from a formal requirement into a strategic engine of safety, performance, competitiveness,…
Ready for the next draft: what will change in the regulation of AI medical devices by 2026
There’s a silent revolution underway in the way we regulate Artificial Intelligence in medicine. For years, the conversation has been all about validation: collecting data, measuring performance, defining protocols, proving that the model works.The logic was linear: if it works, it can be certified. But 2026 marks a turning point.It will no longer be enough…
The Expert Take | When RCTs aren’t the best choice: finding the right study design for Medical Devices
“RCTs are the gold standard.” That’s the mantra we all know in clinical research, and it’s true. Or rather, almost true. Because when it comes to medical devices, that model starts to crack.Devices live in a reality that’s dynamic, operator-dependent, and constantly evolving.Recognizing when an RCT isn’t the right choice doesn’t mean lowering the bar: it means…
MDR 2025: What’s Really Changing and How to Prepare Now
The MDR deadline extension is not a pause. It’s a strategic opportunity – but only if you act early. Back in early 2024, the European Commission granted more time for companies to align with Regulation (EU) 2017/745 (MDR) – particularly concerning legacy devices. While many manufacturers welcomed the extra breathing room, be careful: more time doesn’t mean fewer…
MDR – Racing Against Time for Your CE Mark
The extension is here, but it’s not a safety net. Learn how to move fast, stay compliant, and protect your market share. With Regulation (EU) 2023/607, the European Commission has introduced a critical extension to MDR deadlines for legacy devices certified under the previous MDD (Directive 93/42/EEC). It’s a valuable opportunity—but not an excuse to delay.…
English